Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 86277 refers to a laboratory test that measures the levels of antibodies against human growth hormone (HGH) in the blood. This test is particularly relevant for individuals who are undergoing treatment with recombinant human growth hormone (rhGH), as these patients may develop antibodies that can neutralize the effects of the administered growth hormone. The presence of these antibodies can significantly impact the efficacy of the treatment, making it essential to monitor their levels regularly. The test involves obtaining a blood sample through a procedure known as venipuncture, which is reported separately. The serum obtained from the blood sample is then analyzed using a radiobinding assay, a specific laboratory technique that allows for the accurate measurement of the antibody levels. This test is crucial for healthcare providers to assess the patient's response to rhGH therapy and to make informed decisions regarding ongoing treatment plans.
© Copyright 2026 Coding Ahead. All rights reserved.
The test coded as CPT® 86277 is indicated for the following conditions:
The procedure for conducting the test associated with CPT® 86277 involves several key steps:
After the procedure, the patient may experience minor discomfort or bruising at the venipuncture site, which is generally temporary. There are no specific post-procedure care instructions provided in the data; however, patients are typically advised to keep the site clean and dry. The results of the test will be analyzed and reported to the healthcare provider, who will use this information to assess the patient's response to rhGH therapy and make any necessary adjustments to the treatment plan.
| Short Descr | GROWTH HORMONE ANTIBODY | Medium Descr | GROWTH HORMONE HUMAN ANTIBODY | Long Descr | Growth hormone, human (HGH), antibody | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 235 - Other Laboratory |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.